Cell Care Therapeutics
Cell Care Therapeutics: A California-based biopharmaceutical firm specializing in regenerative immunotherapies.
Founded
2014Cell Care Therapeutics: A California-based biopharmaceutical firm specializing in regenerative immunotherapies.
Founded in California, Cell Care Therapeutics is a biopharmaceutical company dedicated to developing regenerative immunotherapies. The company's core mission is to create innovative biologics that address blood vessel degeneration and inflammation. Utilizing a novel secretome platform, Cell Care Therapeutics harnesses the signaling molecules from mesenchymal stromal cells (MSCs) to promote vascular health. Their primary focus is on developing treatments for conditions such as diabetic retinopathy.
Notable figures associated with Cell Care Therapeutics include leading scientists and industry experts in regenerative medicine. The company has attracted significant investment from prominent venture capital firms in the biotech sector. Key achievements include advancing their secretome platform and initiating clinical trials for their first product targeting diabetic retinopathy. Overall, Cell Care Therapeutics is making a substantial impact in the field of regenerative medicine by pioneering new treatments for vascular diseases.
Companies similar to Cell Care Therapeutics include Secretome Therapeutics, ViaCyte, Caeregen Therapeutics and Stemedica Cell Technologies.
Cell Care Therapeutics was founded in 2014.
Cell Care Therapeutics' headquarters is located in Monrovia, CA, US.
Cell Care Therapeutics' most recent funding round was for $4.3M (USD) in October 2018.
As of Oct 23, 2018, Cell Care Therapeutics has disclosed funding of $5.3M (USD). Undisclosed round amounts are excluded.
Cell Care Therapeutics has 7 employees as of Feb 5, 2024.
Stemedica Cell Technologies
stemedica.com
